Our MAPS study team
We are trying to understand the long term complications of cancer therapies, and to foster and research ways to improve the health outcomes of all individuals who have been treated for cancer. Dr. Anne Blaes, the lead-investigator of our research team, is an Associate Professor in the Division of Hematology and Oncology at the University of Minnesota. She is an active medical oncologist with a special interest in the late effects of cancer therapy, particularly in the area of cardio-oncology. As director of the University of Minnesota’s Adult Cancer Survivor Program, she collaborates with other researchers in designing and implementing strategies to help prevent cancer treatment complications, particularly in the areas of cardiovascular health, secondary cancers and quality of life. She is an active member of the American Society of Clinical Oncology’s Survivorship Committee, an ALLIANCE for Cancer Clinical Trials Health Outcomes Committee member, and an active member of the International Cardio Oncology Society.
Within the MAPS study team, there are several other key individuals involved in the management, enrollment and study of this project:
Dr. Hee Yun Lee, Ph.D., M.S.W. – a behavioral health scientist at the University of Alabama with a special interest in health behavior change using mobile health technology, cancer screening disparity in underserved minority populations; social/cultural determinants of health; cancer survivorship and culturally tailored intervention strategies; health literacy and its link to health disparity; and global health.
Dr. Rachel Vogel, Ph.D. – a biostatistician and epidemiologist at the University of Minnesota with a special interest in melanoma and gynecologic cancer survivors
Dr. Patricia Jewett, Ph.D. – a postdoctoral fellow at the University of Minnesota with a special interest on data analysis and outcomes in cancer survivors
Susan Flesch, CRA – Ms. Flesch is an experienced clinical research associate with expertise in recruiting adult cancer survivors to participate in clinical trials. She maintains certification with the Society of Clinical Research Associates and will be responsible for the direct implementation of the study. Her responsibilities will include assisting the Principal Investigators with regulatory approvals and compliance (IRB, Scientific Review Committees, etc.), coordinating and serving as the primary point of contact for collaborating sites, recruiting, consenting and retaining subjects in the study, assisting with database and website set up, data entry, conducting medical record abstractions to obtain treatment history for all consent subjects, etc.
A list of other collaborators within our Cancer Survivor Program at the University of Minnesota are available here: